癌症患者念珠菌血症的危险因素：一项病例对照研究。
Risk factors for candidemia in cancer patients: a case-control study.
作者信息
Karabinis A, Hill C, Leclercq B, Tancrède C, Baume D, Andremont A
机构信息
Service de Microbiologie Médicale, Institut Gustave-Roussy, Villejuif, France.
出版信息
J Clin Microbiol. 1988 Mar;26(3):429-32. doi: 10.1128/jcm.26.3.429-432.1988.
Abstract
Risk factors for candidemia were analyzed in a case-control study of 30 cancer patients with candidemia and 58 controls. In a univariate analysis, previous surgery, neutropenia, central catheterization, chemotherapy, specific antibiotic treatments, and peripheral cultures positive for Candida spp. were associated with a significantly increased risk of candidemia. In a multivariate logistic model, the significant risk factors for candidemia were positive peripheral cultures for Candida spp. (P = 0.02), central catheterization (P = 0.03), and neutropenia (P = 0.05). These results should help to identify cancer patients with a high risk of candidemia, who should be given early systemic antifungal therapy.
摘要
在一项针对30例念珠菌血症癌症患者和58例对照的病例对照研究中，分析了念珠菌血症的危险因素。在单因素分析中，既往手术、中性粒细胞减少、中心静脉置管、化疗、特定抗生素治疗以及念珠菌属外周血培养阳性与念珠菌血症风险显著增加相关。在多因素逻辑模型中，念珠菌血症的显著危险因素为念珠菌属外周血培养阳性（P = 0.02）、中心静脉置管（P = 0.03）和中性粒细胞减少（P = 0.05）。这些结果应有助于识别念珠菌血症高危癌症患者，应对其尽早给予全身抗真菌治疗。
相似文献
1
Risk factors for candidemia in cancer patients: a case-control study.癌症患者念珠菌血症的危险因素：一项病例对照研究。
J Clin Microbiol. 1988 Mar;26(3):429-32. doi: 10.1128/jcm.26.3.429-432.1988.
2
Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.高剂量粒细胞输注对念珠菌血症癌症患者的影响：491例念珠菌属血流感染病例的回顾性病例对照分析
Cancer. 2004 Dec 15;101(12):2859-65. doi: 10.1002/cncr.20710.
3
Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes.血液系统恶性肿瘤患者念珠菌血症的回顾性研究。76例病例的临床特征、危险因素及转归
Eur J Haematol. 1999 Aug;63(2):77-85. doi: 10.1111/j.1600-0609.1999.tb01120.x.
4
Risk factors for candidemia in patients with acute lymphocytic leukemia.
Rev Infect Dis. 1991 Mar-Apr;13(2):211-5. doi: 10.1093/clinids/13.2.211.
5
Risk factors for candidemia-related mortality at a medical center in central Taiwan.台湾中部某医学中心念珠菌血症相关死亡率的危险因素。
J Microbiol Immunol Infect. 2006 Apr;39(2):155-61.
6
The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.侵袭性念珠菌病流行病学的变化：光滑念珠菌和克柔念珠菌成为血液系统恶性肿瘤患者念珠菌血症的主要病因。
Cancer. 2008 Jun;112(11):2493-9. doi: 10.1002/cncr.23466.
7
Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol.癌症患者血源性毛孢子菌病：12例报告，其中5例为接受伊曲康唑预防治疗期间发病。
Support Care Cancer. 1999 Jan;7(1):39-43. doi: 10.1007/s005200050221.
8
Systemic candidiasis in cancer patients.癌症患者的系统性念珠菌病
Am J Med. 1984 Oct 30;77(4D):20-7.
9
Breakthrough candidemia in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity.癌症患者的突破性念珠菌血症在宿主因素和念珠菌种类方面与新发念珠菌血症不同，但在严重程度上并无差异。
Infect Control Hosp Epidemiol. 2002 Sep;23(9):542-5. doi: 10.1086/502104.
引用本文的文献
1
When Is It Appropriate to Take Off the Mask? Signaling Pathways That Regulate ß(1,3)-Glucan Exposure in .何时适合摘下口罩？调节β(1,3)-葡聚糖暴露的信号通路
Front Fungal Biol. 2022 Mar;3. doi: 10.3389/ffunb.2022.842501. Epub 2022 Mar 9.
2
Prediction of Prognostic Risk Factors in Patients with Invasive Candidiasis and Cancer: A Single-Centre Retrospective Study.侵袭性念珠菌病和癌症患者预后危险因素预测：一项单中心回顾性研究。
Biomed Res Int. 2022 Jun 2;2022:7896218. doi: 10.1155/2022/7896218. eCollection 2022.
3
Candidemia Risk Prediction (CanDETEC) Model for Patients With Malignancy: Model Development and Validation in a Single-Center Retrospective Study.恶性肿瘤患者念珠菌血症风险预测（CanDETEC）模型：单中心回顾性研究中的模型开发与验证
JMIR Med Inform. 2021 Jul 26;9(7):e24651. doi: 10.2196/24651.
4
Infectious Causes of Eosinophilic Meningitis in Korean Patients: A Single-Institution Retrospective Chart Review from 2004 to 2018.韩国患者嗜酸性粒细胞性脑膜炎的感染性病因：2004 年至 2018 年单机构回顾性图表审查。
Korean J Parasitol. 2021 Jun;59(3):227-233. doi: 10.3347/kjp.2021.59.3.227. Epub 2021 Jun 21.
5
Epidemiological Trends of Candidemia and the Impact of Adherence to the Candidemia Guideline: Six-Year Single-Center Experience.念珠菌血症的流行病学趋势及遵循念珠菌血症指南的影响：六年单中心经验
J Fungi (Basel). 2021 Apr 6;7(4):275. doi: 10.3390/jof7040275.
6
"De-escalation" strategy using micafungin for the treatment of systemic infections: budget impact in France and Germany.使用米卡芬净治疗全身性感染的“降阶梯”策略：对法国和德国的预算影响
Clinicoecon Outcomes Res. 2017 Dec 5;9:763-774. doi: 10.2147/CEOR.S141548. eCollection 2017.
7
Evaluation of candidemia in epidemiology and risk factors among cancer patients in a cancer center of China: an 8-year case-control study.中国某癌症中心癌症患者念珠菌血症的流行病学及危险因素评估：一项为期8年的病例对照研究
BMC Infect Dis. 2017 Aug 3;17(1):536. doi: 10.1186/s12879-017-2636-x.
8
Candida colonization as a risk marker for invasive candidiasis in mixed medical-surgical intensive care units: development and evaluation of a simple, standard protocol.念珠菌定植作为内科-外科混合重症监护病房侵袭性念珠菌病的风险标志物：一种简单标准方案的制定与评估
J Clin Microbiol. 2015 Apr;53(4):1324-30. doi: 10.1128/JCM.03239-14. Epub 2015 Feb 11.
9
Commensal enteric bacteria lipopolysaccharide impairs host defense against disseminated Candida albicans fungal infection.共生肠道细菌脂多糖会损害宿主对播散性白色念珠菌真菌感染的防御能力。
Mucosal Immunol. 2015 Jul;8(4):886-95. doi: 10.1038/mi.2014.119. Epub 2014 Dec 10.
10
Spectrum of fungal infection in a neurology tertiary care center in India.印度一家神经科三级护理中心的真菌感染谱。
Neurol Sci. 2012 Dec;33(6):1305-10. doi: 10.1007/s10072-012-0932-1. Epub 2012 Jan 19.
本文引用的文献
1
The value of fungal surveillance cultures as predictors of systemic fungal infections.真菌监测培养作为系统性真菌感染预测指标的价值。
J Infect Dis. 1980 Oct;142(4):503-9. doi: 10.1093/infdis/142.4.503.
2
Fungal infections in patients with acute leukemia.急性白血病患者的真菌感染
Am J Med. 1982 Oct;73(4):543-8. doi: 10.1016/0002-9343(82)90334-5.
3
Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia.针对长期发热且粒细胞减少的癌症患者的经验性抗生素和抗真菌治疗。
Am J Med. 1982 Jan;72(1):101-11. doi: 10.1016/0002-9343(82)90594-0.
4
Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality.免疫功能低下宿主的真菌血症。模式改变、抗原血症、高死亡率。
Am J Med. 1981 Sep;71(3):363-70. doi: 10.1016/0002-9343(81)90162-5.
5
Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia.急性髓系白血病缓解诱导治疗期间侵袭性真菌病相关因素的多变量分析。
Cancer. 1984 Feb 1;53(3):411-9. doi: 10.1002/1097-0142(19840201)53:3<411::aid-cncr2820530308>3.0.co;2-e.
6
Current trends in immunodiagnosis of candidiasis and aspergillosis.念珠菌病和曲霉病免疫诊断的当前趋势。
Rev Infect Dis. 1984 May-Jun;6(3):301-12. doi: 10.1093/clinids/6.3.301.
7
Serial enzyme-linked immunosorbent assays for antibody to Candida antigens during induction chemotherapy for acute leukemia.急性白血病诱导化疗期间念珠菌抗原抗体的系列酶联免疫吸附测定。
J Infect Dis. 1983 Aug;148(2):275-83. doi: 10.1093/infdis/148.2.275.
8
Systemic candidiasis in cancer patients.癌症患者的系统性念珠菌病
Am J Med. 1984 Oct 30;77(4D):20-7.
9
Candidiasis in cancer patients.癌症患者的念珠菌病。
Am J Med. 1984 Oct 30;77(4D):13-9.
10
Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy.一家癌症医院的真菌血症：发生率的变化、发病时间的提前及治疗结果
Rev Infect Dis. 1985 Sep-Oct;7(5):646-55. doi: 10.1093/clinids/7.5.646.
Zotero 插件